RESEARCH ARTICLE – Pharmaceutics, Drug Delivery and Pharmaceutical TechnologyUnderstanding and Managing the Impact of HPMC Variability on Drug Release from Controlled Release Formulations
Section snippets
INTRODUCTION
Extended-release (ER) dosage forms may provide a number of benefits including reduced dosing frequency, improved efficacy, reduced adverse events, and improved patient compliance, and therefore have competitive advantages over their immediate release counterparts. Among the various types of ER dosage forms, the hydrophilic matrix is the most widely used platform of drug delivery. It is versatile and can accommodate both low and high drug loading, and drug molecules with a wide range of
Materials
Batches of HPMC, substituent grade of USP hypromellose 2208, and viscosity grade of 15,000 mPa s were obtained from Dow (Dow Chemicals, Michigan), Shin-Etsu (Shin-Etsu Chemical Company Ltd., Tokyo, Japan), and Hercules (Hercules Doel BVBA, Doel, Belgium), which are commercially designated as K15M, METOLOSE 90SH-15000, and Benecel® K15M PH, respectively. Niacin was obtained from Lonza AG (Visp, Switzerland), stearic acid was obtained from PMC Biogenix (Memphis, Tennessee), and Povidone K90D was
RESULTS AND DISCUSSION
Niacin ER tablet is an ER hydrophilic matrix tablet based on HPMC. It has a high drug loading and approximately 16% HPMC. Figure 1 is a control chart of niacin release at 20 h, hereafter designated as D20h, segmented by the HPMC lot used in the manufacture. Although all these HPMC lots were obtained from a single vendor, it is apparent that the drug release was impacted by the lot of HPMC. Some of the tablet lots barely passed the lower specification limit of not less than 75% and several lots
CONCLUSIONS
Variability in the dissolution performance of an ER product was investigated by focusing on a basic understanding of HPMC, the release-controlling excipient. Although the conventional DOEs based on the overall substitution levels, viscosity, and particle size did not fully mitigate the variability, investigations of the structural aspect of HPMC revealed significant chemical and spatial heterogeneity between vendors and potentially within the same vendor. Extensive review of drug release
ACKNOWLEDGMENT
Conflict of interest: This study was funded by AbbVie Inc. AbbVie participated in the study design, research, data collection, analyses, and interpretation of data, as well as writing, reviewing, and approving the publication. All authors are either current or former AbbVie employees and may own AbbVie stock/options.
REFERENCES (32)
- et al.
Prediction of polymer dissolution in swellable controlled-release systems
J Control Release
(1987) - et al.
Swelling of hydroxypropyl methylcellulose matrix tablets. 1. Characterization of swelling using a novel optical imaging method
J Pharm Sci
(1996) - et al.
Probing the mechanisms of drug release from hydrogels
J Control Release
(1991) - et al.
A simple equation for description of solute release
II. Fickian and anomalous release from swellable devices. J Control Release
(1987) - et al.
A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or disks
J Control Release
(1987) - et al.
Influence of physicochemical properties of hydroxypropyl methyl cellulose on naproxen release from sustained release matrix tablets
J Control Release
(1990) - et al.
Polymer erosion and drug release characterization of hydroxypropyl hethylcellulose matrices
J Pharm Sci
(1998) - et al.
Characterisation of the substituent distribution in starch and cellulose derivatives
Anal Chim Acta
(2003) - et al.
Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets
Eur J Pharm Sci
(2009) - et al.
The effect of chemical heterogeneity of HPMC on polymer release from matrix tablets
Eur J Pharm Sci
(2009)
Effect of hydroxypropyl cellulose (HPC) on dissolution rate of hydrochlorothiazide tablets
Int J Pharm
Model drug release from matrix tablets composed of HPMC with different substituent heterogeneity
Int J Pharm
Translocation of drug particles in HPMC matrix gel layer: Effect of drug solubility and influence on release rate
J Control Release
Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport
J Control Release
Using methocel cellulose ethers for controlled release of drugs in hydrophilic matrix systems
Methocel cellulose ethers technical handbook
Cited by (34)
Leveraging a multivariate approach towards enhanced development of direct compression extended release tablets
2023, International Journal of PharmaceuticsHydroxypropyl Methylcellulose Phthalate Biopolymer as an Anticorrosion Coating
2021, International Journal of Electrochemical ScienceMethyl cellulose solutions and gels: fibril formation and gelation properties
2021, Progress in Polymer ScienceCitation Excerpt :As with MC, these various cellulose ethers are prepared through the substitution of hydroxyl groups in the 2, 3, and 6 positions around the cellulose ring [83,84]. In addition to sharing typical MC applications, hydroxy-propyl methyl cellulose (HPMC) has found uses ranging from the production of films [85–88] and thermoplastics [89,90], applications in biomedicine [91] and drug delivery [92–98], and in 3D printing [99]. The chemical structure of HPMC is almost identical to MC, with the addition of hydroxy-propyl substituents at typical levels (MS) from 0.1 to 0.3 per AGU, and comparative studies of the phase separation and gelation behavior in aqueous solutions are extensive [9,13,29,43,100–107].
A Raman imaging-based technique to assess HPMC substituent contents and their effects on the drug release of commercial extended-release tablets
2020, Carbohydrate PolymersCitation Excerpt :As one of the most commonly used release-controlling polymers, hydroxypropyl methylcellulose (HPMC) is a polysaccharide decorated with Methoxyl (MeO) and Hydroxypropoxyl (HPO) groups. HPMC has been extensively used to prepare extended-release hydrophilic matrix tablets due to its superior properties, including excellent safety, biodegradability, biocompatibility, high drug-loading capacity, etc (The Dow Chemical Company, Methocel cellulose ethers technical handbook, 2002; The Dow Chemical Company, Using methocel cellulose ethers for controlled release of drugs in hydrophilic matrix systems, 2000; Guiastrennec, Soderlind, Richardson, Peric, & Bergstrand, 2017; Klein et al., 2018; Mohamed et al., 2013; Zhou et al., 2014). HPMC can be classified into different types and grades, which are determined by the MeO and HPO substitution degrees and the molecular weight, respectively.
Polymeric and lipid-based systems for controlled drug release: An engineering point of view
2019, Nanomaterials for Drug Delivery and Therapy